Related content

Effect of rifampicin on the pharmacokinetics of imatinib mesylate (Gleevec, STI571) in healthy subjects

By Bolton Ann   Peng Bin   Hubert Martine   Krebs-Brown Axel   Capdeville Renaud   Keller Urs   Seiberling Michael  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 2, 2004-02 ,pp. : 102-106

Springer Publishing Company

Access to resources Recommend Favorite

Clinical pharmacokinetics of Icotinib, an anti-cancer drug: evaluation of dose proportionality, food effect, and tolerability in healthy subjects

By Liu Dongyang   Jiang Ji   Zhang Li   Tan Fenlai   Wang Yingxiang   Zhang Don   Hu Pei  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 4, 2014-04 ,pp. : 721-727

Springer Publishing Company

Access to resources Recommend Favorite

Dexamethasone as a probe for CYP3A4 metabolism: evidence of gender effect

By Puisset F.   Chatelut E.   Sparreboom A.   Delord J.-P.   Berchery D.   Lochon I.   Lafont T.   Roché H.  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 2, 2007-07 ,pp. : 305-308

Springer Publishing Company

Access to resources Recommend Favorite

Investigation into CYP3A4-mediated drug–drug interactions on midostaurin in healthy volunteers

By Dutreix Catherine   Munarini Florence   Lorenzo Sebastien   Roesel Johannes   Wang Yanfeng  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 6, 2013-12 ,pp. : 1223-1234

Springer Publishing Company

Access to resources Recommend Favorite

Effect of CYP2C19 and CYP3A4 gene polymorphisms on the efficacy of bortezomib-based regimens in patients with multiple myeloma

By          

Oncology Letters, Vol. 10, Iss. 2, 2015-01 ,pp. : 1171-1175

Spandidos Publications

Access to resources Recommend Favorite